Interstitial pneumonia

Interstitial pneumonia refers to a group of lung disorders where inflammation and scarring primarily affect the tissue surrounding the alveoli, disrupting oxygen transfer and lung flexibility. The causes are diverse, ranging from autoimmune conditions and environmental exposures to medications and unknown origins. Patients often experience progressive shortness of breath, dry cough, fatigue, and sometimes weight loss. Diagnosis of interstitial pneumonia relies on high-resolution imaging to visualize lung tissue, pulmonary function tests to evaluate airflow and gas exchange, and occasionally biopsy to identify the nature of the inflammation. Early recognition is critical to implement interventions that slow disease progression and prevent irreversible lung damage, particularly since symptoms may develop gradually and be mistaken for other respiratory issues.

Management strategies focus on controlling inflammation, maintaining lung function, and minimizing complications. Corticosteroids and immunosuppressive medications are commonly prescribed depending on disease severity and underlying causes. Supportive measures such as supplemental oxygen, pulmonary rehabilitation, and exercise programs improve endurance and symptom management. Avoiding environmental triggers like dust or chemical irritants reduces exacerbations. Regular monitoring through imaging and lung function assessments allows clinicians to track disease progression and adjust therapy accordingly. Patient education regarding symptom monitoring, adherence to therapy, and lifestyle modifications is crucial for optimizing outcomes and maintaining long-term respiratory health.